Catalent, Inc.

CTLT11 Dec 2024
Healthcare
$62.5
0.00 (-0.21%)
Lowest Today
$62.21
Highest Today
$62.5
Today’s Open
$62.5
Prev. Close
$62.37
52 Week High
$62.5
52 Week Low
$37.03
To Invest in Catalent, Inc.

Catalent, Inc.

Healthcare
CTLT11 Dec 2024
0.00 (-0.21%)
1M
3M
6M
1Y
5Y
Low
$62.21
Day’s Range
High
$62.5
62.21
52 Week Low
$37.03
52-Week Range
52 Week High
$62.5
37.03
1 Day
-
1 Week
+0.77%
1 month return
+4.65%
3 month return
+4.48%
6 month return
+11.55%
1 Year return
+64.18%
3 Years return
-50.18%
5 Years return
+19.29%
10 Years return
-
Institutional Holdings
Vanguard Group Inc
11.15
BlackRock Inc
8.46
State Street Corp
4.1
Capital World Investors
3.53
Vanguard Total Stock Mkt Idx Inv
2.99
Vanguard Institutional 500 Index Trust
2.64
NORGES BANK
2.53

Market Status

Fundamentals
Market Cap
11320.9 mln
PB Ratio
3.17
PE Ratio
0
Enterprise Value
15834.86 mln
Total Assets
9753 mln
Volume

Company Financials

Fund house & investment objective

Company Information
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. It operates in two segments, Biologics, and Pharma and Consumer Health. The Biologics segment provides formulation, development, and manufacturing for biologic proteins, cell gene, and other nucleic acid therapies; pDNA, iPSCs, oncolytic viruses, and vaccines; formulation, development, and manufacturing for parenteral dose forms, including vials, prefilled syringes, and cartridges; and analytical development and testing services for large molecules. The Pharma and Consumer Health segment offers formulation, development, and manufacturing services for soft capsules for use in a range of customer products, such as prescription drugs, over-the-counter medications, dietary supplements, unit-dose cosmetics, and animal health medicinal preparations; and oral, nasal, inhaled, and topical dose forms. This segment also provides clinical supply services through manufacturing, packaging, storage, distribution, and inventory management for small-molecule drugs, protein-based biologics, and cell and gene therapies in clinical trials; and pre-clinical screening, formulation, analytical development, and current good manufacturing practices manufacturing at clinical and commercial scale for softgel capsule, Zydis fast-dissolve tablets, oral solid-dose formats, dry powder inhalers, and nasal delivery devices. The company also offers FlexDirect direct-to-patient and FastChain demand-led clinical supply solutions; fill and finish operations for injectable products; and integrated development and product supply chain solutions. It serves biotechnology, pharmaceutical, and consumer health companies; and companies in other healthcare market segments, such as animal health and medical devices, as well as in cosmetics industries. The company was founded in 1933 and is headquartered in Somerset, New Jersey.
Organisation
Catalent, Inc.
Employees
17000
Industry
Drug Manufacturers - Specialty & Generic
CEO
Mr. Alessandro  Maselli
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:

Take your next step